Atherothrombotic complications are the main cause of mortality in subjects with diabetes.
Premature atherosclerosis, increased platelet reactivity and activation of coagulation factors …

Atherothrombotic disease arises secondary to a complex gene–environment interaction. In
the initial stages, the condition is clinically silent but with more advanced disease, an …

Background This represents the first update of this review, which was published in 2012.
Atorvastatin is one of the most widely prescribed drugs and the most widely prescribed statin …

Recent data from genetic and epidemiological studies strongly support a causal relationship
between elevated lipoprotein (a)[Lp (a)] concentrations and the development of …

Endothelial dysfunction has been shown to be a prognostic factor for cardiovascular disease
and improvement of endothelial dysfunction prevents cardiovascular event presentation …

Elevated levels of lipoprotein (a) are causally related to premature atherosclerosis. It is
therefore of interested to evaluate by which treatment modalities elevated lipoprotein (a) …

The endothelium is a dynamic organ that plays a pivotal role in cardiovascular homeostasis.
Alteration in endothelial function precedes the development of atherosclerosis and …

Altered levels of soluble biomarkers are associated with cardiovascular disease, and
profiling of multiple biomarkers for atherosclerosis will be a useful indicator for better risk …

Atherothrombotic disease remains a major cause of mortality worldwide, and family
clustering suggests an important contribution of genetic factors to disease pathogenesis …

Beneficial effects of aggressive lipid-lowering with high-dose atorvastatin (80 mg/day) have
been demonstrated in patients with coronary and cerebrovascular disease. The impact of …